Table 4. Multivariate Model for progression-free survival in Low Grade Gliomas.
Parameter | P | HR | 95% CI | ||
---|---|---|---|---|---|
TERT promoter | Mutation | 0.01 | 10.21 | 1.87 | 55.87 |
IDH | Mutation | 0.10 | 2.03 | 0.87 | 4.73 |
1p/19q co-deletion | Deletion | 0.0001 | 0.03 | 0.004 | 0.17 |
CDKN2A/B | Deletion | 0.43 | 1.35 | 0.64 | 2.85 |
Treatment - Group | CCNU | 0.43 | 0.60 | 0.17 | 2.14 |
Treatment - Group | Carmustin | 0.23 | 3.89 | 0.42 | 36.28 |
Treatment - Group | PC | 0.16 | 1.70 | 0.81 | 3.56 |
Treatment - Group | none | 0.005 | 0.22 | 0.08 | 0.63 |
Age | 0.81 | 1.00 | 0.97 | 1.04 |